Beate Sander

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. pmc Reactive strategies for containing developing outbreaks of pandemic influenza
    Sigrún Andradóttir
    H Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA
    BMC Public Health 11:S1. 2011
  2. pmc Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis
    Beate Sander
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
    PLoS Med 7:e1000256. 2010
  3. pmc Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
    Beate Sander
    Department of Health Policy, Management and Evaluation, University of Toronto, Canada
    Value Health 12:226-33. 2009
  4. ncbi Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom
    Beate Sander
    Institute for Medical Outcome Research GmbH, Lörrach, Germany
    Eur J Health Econ 6:244-52. 2005
  5. ncbi Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK
    Beate Sander
    Division of Clinical Decision Making and Health Care Research, University Health Network, Toronto, Ontario, Canada
    Pharmacoeconomics 24:373-86. 2006
  6. doi Time and motion study to compare electronic and hybrid data collection systems during the pandemic (H1N1) 2009 influenza vaccination campaign
    Susan Quach
    Surveillance and Epidemiology, Ontario Agency for Health Protection and Promotion, Toronto, Canada
    Vaccine 29:1997-2003. 2011
  7. doi Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience
    Beate Sander
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
    Vaccine 28:6210-20. 2010
  8. pmc Perceptions of immunization information systems for collecting pandemic H1N1 immunization data within Canada's public health community: a qualitative study
    Christine L Heidebrecht
    Department of Surveillance and Epidemiology, Ontario Agency for Health Protection and Promotion, Toronto, Canada
    BMC Public Health 10:523. 2010
  9. pmc Modelling mitigation strategies for pandemic (H1N1) 2009
    Marija Zivkovic Gojovic
    Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Research Institute of the Hospital for Sick Children, Toronto, ON
    CMAJ 181:673-80. 2009
  10. pmc A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns
    Jennifer A Pereira
    Department of Surveillance and Epidemiology, Public Health Ontario, Toronto, Canada
    BMC Health Serv Res 11:210. 2011

Collaborators

Detail Information

Publications14

  1. pmc Reactive strategies for containing developing outbreaks of pandemic influenza
    Sigrún Andradóttir
    H Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA
    BMC Public Health 11:S1. 2011
    ..This experience suggests the need to explore the epidemiological and economic effectiveness of additional, reactive strategies for combating pandemic influenza...
  2. pmc Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis
    Beate Sander
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
    PLoS Med 7:e1000256. 2010
    ..This is the first large-scale program of its kind worldwide. The objective of this study was to conduct an economic appraisal of Ontario's UIIP compared to a targeted influenza immunization program (TIIP)...
  3. pmc Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
    Beate Sander
    Department of Health Policy, Management and Evaluation, University of Toronto, Canada
    Value Health 12:226-33. 2009
    ..To project the potential economic impact of pandemic influenza mitigation strategies from a societal perspective in the United States...
  4. ncbi Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom
    Beate Sander
    Institute for Medical Outcome Research GmbH, Lörrach, Germany
    Eur J Health Econ 6:244-52. 2005
    ..Oseltamivir dominates usual care from the societal perspective. Treatment with oseltamivir is a cost-effective strategy for otherwise healthy adults in the UK from both the healthcare payer and societal perspective...
  5. ncbi Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK
    Beate Sander
    Division of Clinical Decision Making and Health Care Research, University Health Network, Toronto, Ontario, Canada
    Pharmacoeconomics 24:373-86. 2006
    ..To assess the cost effectiveness and cost utility of preventing post-exposure influenza infection using the neuraminidase inhibitor oseltamivir from a healthcare payer's perspective in the UK...
  6. doi Time and motion study to compare electronic and hybrid data collection systems during the pandemic (H1N1) 2009 influenza vaccination campaign
    Susan Quach
    Surveillance and Epidemiology, Ontario Agency for Health Protection and Promotion, Toronto, Canada
    Vaccine 29:1997-2003. 2011
    ..Electronic registration and record keeping were faster than paper-based methods; these findings should be used to improve data collection for future influenza seasons...
  7. doi Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience
    Beate Sander
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
    Vaccine 28:6210-20. 2010
    ....
  8. pmc Perceptions of immunization information systems for collecting pandemic H1N1 immunization data within Canada's public health community: a qualitative study
    Christine L Heidebrecht
    Department of Surveillance and Epidemiology, Ontario Agency for Health Protection and Promotion, Toronto, Canada
    BMC Public Health 10:523. 2010
    ....
  9. pmc Modelling mitigation strategies for pandemic (H1N1) 2009
    Marija Zivkovic Gojovic
    Toronto Health Economics and Technology Assessment Collaborative, University of Toronto, Research Institute of the Hospital for Sick Children, Toronto, ON
    CMAJ 181:673-80. 2009
    ..Simulation models can be used to project the effectiveness of mitigation strategies, but the choice of the best scenario may change depending on model assumptions and uncertainties...
  10. pmc A cost comparison of electronic and hybrid data collection systems in Ontario during pandemic and seasonal influenza vaccination campaigns
    Jennifer A Pereira
    Department of Surveillance and Epidemiology, Public Health Ontario, Toronto, Canada
    BMC Health Serv Res 11:210. 2011
    ..The objective of our evaluation was to compare projected five-year costs associated with implementing these systems in Ontario public health units (PHUs) during pandemic and seasonal influenza vaccination campaigns...
  11. doi A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs
    Beate Sander
    Division of Clinical Decision Making and Health Care Research, University Health Network, 200 Elizabeth Street, EN 13 239, Toronto, ON M5G 2C4, Canada
    J Bone Joint Surg Am 90:1197-205. 2008
    ..We report the results of an analysis of the cost-effectiveness of the use of a coordinator (in comparison with the use of no coordinator) in avoiding future costs of subsequent hip fracture...
  12. pmc Is a Mass Immunization Program for Pandemic (H1N1) 2009 Good Value for Money? Early Evidence from the Canadian Experience
    Beate Sander
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada University of Guelph Dalla Lana School of Public Health, University of Toronto Sunnybrook Hospital, The University of Toronto Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto Toronto Health Economics and Technology Assessment Collaborative THETA and University of Toronto
    PLoS Curr 1:RRN1137. 2009
    ..Our analysis indicates this program will reduce influenza cases by 50%, preventing 35 deaths, and cutting treatment costs in half. A pandemic (H1N1) 2009 immunization program is likely to be highly cost-effective...
  13. doi Preventing pressure ulcers in long-term care: a cost-effectiveness analysis
    Ba Pham
    TorontoHealth Economics and Technology Assessment Collaborative, Department of Health Policy Management andEvaluation, University of Toronto, 144 College Street, Toronto, Ontario, Canada
    Arch Intern Med 171:1839-47. 2011
    ..Pressure ulcers are common in many care settings, with adverse health outcomes and high treatment costs. We evaluated the cost-effectiveness of evidence-based strategies to improve current prevention practice in long-term care facilities...
  14. ncbi The cost-effectiveness of pneumococcal conjugate vaccination in Australia
    James R G Butler
    National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia
    Vaccine 22:1138-49. 2004
    ..We undertook an independent economic analysis of PCV7 compared with no vaccination in the non high-risk Australian childhood population using cost-utility and cost-effectiveness measures...